Eli Lilly and Company

Sr Associate - Immunology Medical Science Liaison

Israel

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Requirements

Candidates must possess an advanced degree in health sciences, such as a PharmD, MD, PhD in a medically related field, or a Master’s/Bachelor’s degree in health sciences (e.g., BSN, RPh, PA, NP) with prior experience as an MSL or in the diabetes/Chronic Weight Management Therapeutic Area. Strong English proficiency, both written and oral, is required, along with a passion for science, results, and high standards.

Responsibilities

The Medical Science Liaison will identify and engage with Scientific Experts, providing deep disease state and product expertise, and participating in continuous learning through literature searches and congress participation. They will communicate scientific intelligence and clinical insights, respond to requests, and participate in consultant meetings, driving digital innovation to overcome clinical care gaps. Additionally, the role involves proactive action, asking questions, and translating scientific information into actionable solutions, while effectively communicating scientific data and managing a complex environment.

Skills

Scientific expertise
Literature search
Scientific congress participation
Scientific communication
Presentation skills
Digital technologies
Scientific data translation
Project prioritization
Compliance

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Key Metrics

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI